Home » Topics » Disease categories and therapies » Infection

Infection
RSS

DU-6859a and liver dysfunction

March 21, 1997

Phase III results for HNK20

March 21, 1997

New cephalosporins from Kyoto Pharmaceutical Industries

March 21, 1997

Favorable phase III results reported for Cytolex

March 19, 1997

Natural squalene synthase inhibitors discovered by Pfizer

March 19, 1997

Pharmacokinetics and safety of BMS-180680

March 18, 1997

Roche prepares new antiviral agents

March 18, 1997

MRC, Sankyo and Oncogene Science to develop new antiflu drugs

March 14, 1997

Sequus seeks FDA approval for new indication of Amphotec

March 14, 1997

Clinical trial results for Neuprex in hepatectomy and meningococcemia

March 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...